Bridgefront Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $237,993 - $344,085	2,100 New	2,100 $331,000
Q3 2022 Nov 29, 2022	BUY	$75.71 - $119.24 $156,871 - $247,065	2,072 New	2,072 $229,000
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $805,432 - $1.01 Million	-11,609 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $838,750 - $1.96 Million	11,609 New	11,609 $865,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.